- Home
- 应用程序分析
- MPI-2 Stuttering Treatment
- MPI-2 Stuttering Treatment Vs. Eloquent: Stuttering Treatment
MPI-2 Stuttering Treatment 对比 Eloquent: Stuttering Treatment 的使用情况和统计数据
The MPI-2 Stuttering Treatment application is a specially designed tool to provide professional treatment to individuals who stutter.
The Modifying Phonation Intervals (MPI-2) Stuttering Treatment Program is designed to teach mainly adolescents and adults who stutter to achieve generalized stutter-free and normal sounding speech by speaking with a reduced number of short intervals of phonation (PI=phonation interval). The program is a performance-contingent, biofeedback system that employs software (iOS MPI-2 application) and hardware (iPad, iPad Mini, or iPhone and a throat microphone/accelerometer with single earpiece assembly). Targeted PIs are recorded from the surface of the speaker’s throat and their occurrence is automatically fed back to the speaker during treatment.
Special advantages of the MPI-2 are: its development by expert clinical researchers as a complete evidence-based treatment program – including establishment, transfer and maintenance of fluent speech, and its portability –which facilitates a significant role for the client in managing the treatment and the ability to practice newly learned speech patterns away from the clinic setting while being monitored by the software and/or the clinician.
A general description of the MPI-2 Stuttering Treatment Program, along with pre- and post-treatment speaking samples, as well as links to the research publications underlying development of the MPI-2, can be accessed at the MPI-2 website at http://www.mpi2.com.
In order to start the treatment program, the potential client needs to install the MPI-2 Stuttering Treatment Program application first on an iPhone or iPad, and then choose a clinician (via the “Find Clinician” button on the home screen). After the request has been received, the clinician will contact you to evaluate your condition and discussion additional details, including the cost of the clinician’s clinical services. All MPI-2 clinicians have earned master’s degrees as speech-language pathologists and the Certificate of Clinical Competence from the American Speech-Language Hearing Association and are also certified as MPI-2 clinicians.
- Apple 应用商店
- 免费
- 医疗
商店排名
- -
Eloquent provides a guided speech therapy program for stuttering (also called stammering) to help you improve your fluency and develop a confident approach towards speaking.
Using the app, you will be able to:
* Learn various fluency shaping and stuttering modification techniques and practice them without leaving the app.
* Master these techniques by speaking to virtual avatars in various simulations.
* Transfer your skills to the real world through tasks which you complete outside the app.
* Understand your stuttering better and identify your core and secondary behaviors.
* Use Cognitive Behavioral Therapy (CBT) to address social anxiety, recognize unhelpful thoughts and foster a positive mindset towards communication.
* Track your progress through assessments and quick mood checks. Visualize the ups and downs of your fluency phases on a dashboard. Identify the triggers for your bad phases and learn to manage them better.
* Set daily reminders to keep you motivated and engaged so you don’t miss practice.
Download Eloquent: Your journey towards confident communication starts today!
Disclaimer: Eloquent is not a tool for medical diagnosis or treatment. Please consult a doctor before making any medical decisions.
Terms of Use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
- Apple 应用商店
- 免费
- 健康与健身
商店排名
- -
MPI-2 Stuttering Treatment与Eloquent: Stuttering Treatment排名比较
对比 MPI-2 Stuttering Treatment 与 Eloquent: Stuttering Treatment 在过去 28 天内的排名趋势
排名
没有可用的数据
MPI-2 Stuttering Treatment 对比 Eloquent: Stuttering Treatment 的排名,按国家/地区比较
对比 MPI-2 Stuttering Treatment 与 Eloquent: Stuttering Treatment 在过去 28 天内的排名趋势
无数据可显示
通过免费试用版比较任何网站
MPI-2 Stuttering Treatment VS.
Eloquent: Stuttering Treatment
十二月 11, 2024